r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

NT

Nancy Thornberry

Insider · Director · DNLI

Nancy Thornberry files insider transactions with the SEC as a director of Denali Therapeutics (DNLI). We hold 1 disclosed purchase or sale filed since 10 February 2020, 1 of them in the last 90 days.

  • Files forDNLI
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure4 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 8 January 2021 — 2 September 2026Director · Denali Therapeutics (DNLI)15 Form 4 lines · source: SEC Form 4
  • Filed 10 February 2020 — 22 June 2026Director · Schrodinger (SDGR)17 Form 4 lines · source: SEC Form 4
  • Filed 5 December 2023 — 1 May 2026Director · Vertex Pharmaceuticals Inc / Ma (VRTX)9 Form 4 lines · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.